Hexane → N,N,5-Trimethyl-4-[(2,3,4,9-tetrahydro-9-methyl-4-oxo-1H-carbazol-3-yl) methyl]-1H-imidazole-1-sulphonamide

HRID 621201

반응식

HRID 621201 반응식
[CH3:1][N:2]([CH3:7])[S:3](Cl)(=[O:5])=[O:4].[CH3:8][N:9]1[C:21]2[CH2:20][CH2:19][CH:18]([CH2:22][C:23]3[N:24]=[CH:25][NH:26][C:27]=3[CH3:28])[C:17](=[O:29])[C:16]=2[C:15]2[C:10]1=[CH:11][CH:12]=[CH:13][CH:14]=2.C(N(CC)CC)C.CCCCCC>ClCCl>[CH3:1][N:2]([CH3:7])[S:3]([N:26]1[C:27]([CH3:28])=[C:23]([CH2:22][CH:18]2[C:17](=[O:29])[C:16]3[C:15]4[C:10](=[CH:11][CH:12]=[CH:13][CH:14]=4)[N:9]([CH3:8])[C:21]=3[CH2:20][CH2:19]2)[N:24]=[CH:25]1)(=[O:5])=[O:4]

참가 물질

6

실험 절차

A solution of dimethylsulphamoyl chloride (0.16 ml) in dry dichloromethane was added to a stirred solution of 1,2,3,9-tetrahydro-9-methyl-3-[(5-methyl-1H-imidazol-4-yl)methyl]-4H-carbazol-4-one (438 mg) and triethylamine (0.25 ml) in dry dichloromethane (30 ml) and the mixture was heated at reflux for 18 h. After cooling the reaction mixture was adsorbed onto FCC silica which was then applied to a column and FCC eluting with System A (150:8:1) gave an oil, which solidified to a powder on trituration with dry hexane (30 ml). This powder was then further purified by dissolution in dry dichloromethane (30 ml) and crystallisation by addition of dry hexane (10 ml) to give the title compound (518 mg), m.p. 122°-124°.

후처리

  1. temperaturethe mixture was heated
  2. temperatureat reflux for 18 h
  3. temperatureAfter cooling the reaction mixture
  4. washeluting with System A (150:8:1)
  5. customgave an oil, which
  6. customThis powder was then further purified by dissolution in dry dichloromethane (30 ml)
  7. customcrystallisation
  8. additionby addition of dry hexane (10 ml)

출처 및 근거

ORD 기록
ord-92df16e5fce8404c882045c4791a01ea
출처 데이터셋
uspto-grants-1989_04
특허 번호
US04822881

연결된 노트

불러오는 중…